Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, reminded investors of a securities class action against PROCEPT BioRobotics Corporation, which trades on Nasdaq under the symbol PRCT. The lawsuit alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, a rule addressing securities fraud, promulgated by the U.S. Securities and Exchange Commission (SEC), the U.S. securities regulator. The class period runs from February 28, 2024, through February 25, 2026, and the deadline to contact the firm regarding a possible lead plaintiff appointment is September 22, 2026. The complaint alleges that Procept used large discounts to encourage bulk orders, pulling sales forward and inflating current revenue at the expense of future periods. It also alleges that the company materially overstated utilization of its handpiece units, making its public statements false and materially misleading throughout the class period. Investors allegedly suffered losses after the market learned the truth. Lead plaintiff appointment is not required to participate in any recovery, and the class has not yet been certified. Investors who take no action may remain absent class members. SBS encourages shareholders who suffered losses to contact Brian Schall or David Schwartz to discuss their rights free of charge.